Hyper-fractionated radiotherapy as a bridging strategy to enhance CAR-T efficacy by regulating T-cell co-stimulatory molecules in relapsed/refractory diffuse large B-cell lymphoma
BackgroundBridging therapy can prevent patients from disease progression while waiting for CAR-T cell preparation. Hyper-fractionated radiotherapy can achieve an effective target dose within a short period, minimize radiation damage, and may modify immune environment compared to conventional radioth...
Saved in:
| Main Authors: | Jing Ruan, Daobin Zhou, Yan Zhang, Danqing Zhao, Chong Wei, Ke Hu, Fuquan Zhang, Xiaorong Hou, Wei Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1481080/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
How Co-Stimulatory/Inhibitory Molecules Vary Across Immune Cell Subtypes in the Severity of Systemic Lupus Erythematosus Compared to Controls
by: Kuang-Hui Yu, et al.
Published: (2024-10-01) -
Advances in CAR optimization strategies based on CD28
by: Sijin Li, et al.
Published: (2025-03-01) -
Innovative approaches to CAR-T cell therapy: the role of lipid metabolism pathways
by: Minjie Guo, et al.
Published: (2025-06-01) -
Real-world Australian experience with tisagenlecleucel for relapsed/refractory diffuse large B-cell lymphoma—importance of pre-CAR-T optimization
by: Phoebe Joy Ho, et al.
Published: (2025-08-01) -
Epigenetic modifications and metabolic gene mutations drive resistance evolution in response to stimulatory antibiotics
by: Hui Lin, et al.
Published: (2025-01-01)